Cancer – ACCL1033: A Comprehensive Approach to Improve Medication Adherence in Pediatric ALL
Condition or Therapy:
Cancer and Blood Disorders
Study Number: ACCL1033
What is the goal of this study?
This study is comparing if patients with ALL take their medication better if they are exposed to a multi-component intervention rather than just an educational video.
Who can join the study?
This study may be a good fit for children and young adults who:
- are 1 to 21 years old, and
- have been diagnosed with acute lymphoblastic leukemia.
What will happen if my child takes part in this study?
You can read more about this study on clinicaltrials.gov.
Who can I contact for more information?
To learn more, call 206-987-2106 or email the study coordinator.